Literature DB >> 2106497

Murine gamma interferon fails to inhibit Toxoplasma gondii growth in murine fibroblasts.

J D Schwartzman1, S L Gonias, E R Pfefferkorn.   

Abstract

Although treatment of human macrophages or fibroblasts with human gamma interferon results in the inhibition of intracellular Toxoplasma gondii, murine gamma interferon stimulated only murine macrophages, not murine fibroblasts, to inhibit T. gondii. This species difference may be important in understanding the control of acute and chronic toxoplasmosis.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2106497      PMCID： PMC258541          DOI： 10.1128/iai.58.3.833-834.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  13 in total

1.  Toxoplasma gondii: isolation and preliminary characterization of temperature-sensitive mutants.

Authors:  E R Pfefferkorn; L C Pfefferkorn
Journal:  Exp Parasitol       Date:  1976-06       Impact factor: 2.011

2.  Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan.

Authors:  E R Pfefferkorn; M Eckel; S Rebhun
Journal:  Mol Biochem Parasitol       Date:  1986-09       Impact factor: 1.759

3.  Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts.

Authors:  E R Pfefferkorn; S Rebhun; M Eckel
Journal:  J Interferon Res       Date:  1986-06

Review 4.  Interferons and their actions.

Authors:  S Pestka; J A Langer; K C Zoon; C E Samuel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Growth inhibition of Toxoplasma gondii in cell cultures treated with murine type II interferon.

Authors:  T Shirahata; K Shimizu
Journal:  Nihon Juigaku Zasshi       Date:  1982-12

6.  Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon.

Authors:  E R Pfefferkorn; P M Guyre
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

7.  Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.

Authors:  E R Pfefferkorn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

8.  Strain-dependent differences in murine susceptibility to toxoplasma.

Authors:  F G Araujo; D M Williams; F C Grumet; J S Remington
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

9.  Cleavage of recombinant murine interferon-gamma by plasmin and miniplasmin.

Authors:  S L Gonias; W W Young; J W Fox
Journal:  J Interferon Res       Date:  1989-10

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307
View more
  12 in total

1.  Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.

Authors:  Neide M Silva; Cibele V Rodrigues; Marcelo M Santoro; Luiz F L Reis; Jacqueline I Alvarez-Leite; Ricardo T Gazzinelli
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon.

Authors:  Y Suzuki; F K Conley; J S Remington
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

Review 3.  Mechanisms of innate resistance to Toxoplasma gondii infection.

Authors:  J Alexander; T M Scharton-Kersten; G Yap; C W Roberts; F Y Liew; A Sher
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

4.  Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts.

Authors:  S L Gupta; J M Carlin; P Pyati; W Dai; E R Pfefferkorn; M J Murphy
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

Review 5.  Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.

Authors:  Ira J Blader; Jeroen P Saeij
Journal:  APMIS       Date:  2009-05       Impact factor: 3.205

6.  Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase.

Authors:  A Habara-Ohkubo; T Shirahata; O Takikawa; R Yoshida
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Gamma interferon-mediated inhibition of Eimeria vermiformis growth in cultured fibroblasts and epithelial cells.

Authors:  M E Rose; A L Smith; D Wakelin
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

Review 8.  Role of gamma interferon in Toxoplasma gondii infection.

Authors:  C S Subauste; J S Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

9.  Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii.

Authors:  T M Scharton-Kersten; G Yap; J Magram; A Sher
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

10.  Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.

Authors:  G S Yap; A Sher
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.